§ Funding Round
Series C funding round for Evommune raising $120M in October 2024
Series C funding round for Evommune raising $120M in October 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Arix Bioscience | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$273.5M
Top Valuation
-
Evommune raised $120M in a Series C round.
The round was announced on 10/01/24.
The round was led by RA Capital Management, sectoral asset management.
